Enalare Therapeutics is based in Princeton, New Jersey. It has raised $65M in total funding. Latest round: Seed. Backed by Eagle Pharmaceuticals.
Enalare Therapeutics funding overview
Enalare Therapeutics is based in Princeton, New Jersey. Enalare Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in October 2022. The round record for Enalare Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Eagle Pharmaceuticals.
Enalare Therapeutics at a glance
Total raised
$65M
Latest round
Seed
Latest round date
October 2022
Headquarters
Princeton, New Jersey
Notable investors
Eagle Pharmaceuticals
Frequently asked about Enalare Therapeutics funding
How much has Enalare Therapeutics raised?
Enalare Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Enalare Therapeutics?
Eagle Pharmaceuticals are named among the investors backing Enalare Therapeutics.
What was the latest Enalare Therapeutics funding round?
The most recent disclosed round is a Seed, announced in October 2022.
Where is Enalare Therapeutics based?
Enalare Therapeutics is based in Princeton, New Jersey.
When did Enalare Therapeutics last raise?
The last disclosed Enalare Therapeutics round closed in October 2022 at Seed.
We update the Enalare Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Princeton and their backers are listed below.
